Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-07-068613
Filing Date
2007-09-12
Accepted
2007-09-12 16:46:07
Documents
13
Period of Report
2007-06-30

Document Format Files

Seq Description Document Type Size
1 10-K a07-23410_110k.htm 10-K 1797113
2 EX-2.4 a07-23410_1ex2d4.htm EX-2.4 22122
3 EX-3.1 a07-23410_1ex3d1.htm EX-3.1 14471
4 EX-10.41 a07-23410_1ex10d41.htm EX-10.41 104261
5 EX-10.42 a07-23410_1ex10d42.htm EX-10.42 125139
6 EX-21.1 a07-23410_1ex21d1.htm EX-21.1 5758
7 EX-23.1 a07-23410_1ex23d1.htm EX-23.1 4193
8 EX-23.2 a07-23410_1ex23d2.htm EX-23.2 2944
9 EX-31.1 a07-23410_1ex31d1.htm EX-31.1 9360
10 EX-31.2 a07-23410_1ex31d2.htm EX-31.2 9416
11 EX-32.1 a07-23410_1ex32d1.htm EX-32.1 3978
12 EX-32.2 a07-23410_1ex32d2.htm EX-32.2 4207
13 GRAPHIC g234101be03i001.gif GRAPHIC 6328
  Complete submission text file 0001104659-07-068613.txt   2113349
Mailing Address 345 PARK AVENUE 41ST FLOOR NEW YORK NY 10154
Business Address 345 PARK AVENUE 41ST FLOOR NEW YORK NY 10154 212-750-6700
BIOENVISION INC (Filer) CIK: 0001028205 (see all company filings)

EIN.: 113375915 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 001-31787 | Film No.: 071113621
SIC: 2834 Pharmaceutical Preparations